With 0.57 million shares changed hands, the volume of the stock remained lighter than its average volume of 0.66 million shares. During the session, the Insurance – Life company that operates in wider Financial sector, reached to the highest price of $89.52 whereas the lowest price it dropped to was $87.48. The 52-week range on JXN shows that it touched its highest point at $115.22 and its lowest point at $47.49 during that stretch. It currently has a 1-year price target of $104.20. With its current market cap of 6.48 billion, JXN has annualized dividend of $2.80 while the current yield stands at 3.19%. Beta for the stock currently stands at 1.47.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of JXN was down-trending over the past week, with a drop of -1.93%, but this was down by -12.56% over a month. Three-month performance dropped to -4.07% while six-month performance rose 16.50%. The stock gained 74.04% in the past year, while it has gained 0.79% so far this year. A look at the trailing 12-month EPS for JXN yields -12.45 with Next year EPS estimates of 20.80. For the next quarter, that number is 4.81. This implies an EPS growth rate of 48.33% for this year and 9.22% for next year. EPS is expected to grow by 23.20% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of -12.54%.
Float and Shares Shorts:
At present, 74.35 million JXN shares are outstanding with a float of 72.51 million shares on hand for trading. On 2024-12-13, short shares totaled 3.42 million, which was 463.0 higher than short shares on 1731628800. In addition to Ms. Laura Louene Prieskorn as the firm’s CEO, President & Director, Ms. Carrie Lynn Chelko serves as its Executive VP & General Counsel.
Institutional Ownership:
Through their ownership of 0.94751 of JXN’s outstanding shares, institutional investors have minority control over the company.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for JXN since 2 analysts follow the stock currently. There are 0 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 2 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With JXN analysts setting a high price target of 117.0 and a low target of 88.0, the average target price over the next 12 months is 101.2. Based on these targets, JXN could surge 33.3% to reach the target high and rise by 0.26% to reach the target low. Reaching the average price target will result in a growth of 15.3% from current levels.
Analysts have provided yearly estimates in a range of $19.14731 being high and $18.93456 being low. For JXN, this leads to a yearly average estimate of $19.046.
